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Abstract
The spread of dengue (DEN) worldwide combined with an increased severity of the DEN-associated clinical outcomes have
made this mosquito-borne virus of great global public health importance. Progress in understanding DEN pathogenesis and
in developing effective treatments has been hampered by the lack of a suitable small animal model. Most of the DEN clinical
isolates and cell culture-passaged DEN virus strains reported so far require either host adaptation, inoculation with a high
dose and/or intravenous administration to elicit a virulent phenotype in mice which results, at best, in a productive infection
with no, few, or irrelevant disease manifestations, and with mice dying within few days at the peak of viremia. Here we
describe a non-mouse-adapted DEN2 virus strain (D2Y98P) that is highly infectious in AG129 mice (lacking interferon-a/b
and -c receptors) upon intraperitoneal administration. Infection with a high dose of D2Y98P induced cytokine storm,
massive organ damage, and severe vascular leakage, leading to haemorrhage and rapid death of the animals at the peak of
viremia. In contrast, very interestingly and uniquely, infection with a low dose of D2Y98P led to asymptomatic viral
dissemination and replication in relevant organs, followed by non-paralytic death of the animals few days after virus
clearance, similar to the disease kinetic in humans. Spleen damage, liver dysfunction and increased vascular permeability,
but no haemorrhage, were observed in moribund animals, suggesting intact vascular integrity, a cardinal feature in DEN
shock syndrome. Infection with D2Y98P thus offers the opportunity to further decipher some of the aspects of dengue
pathogenesis and provides a new platform for drug and vaccine testing.
Citation: Tan GK, Ng JKW, Trasti SL, Schul W, Yip G, et al. (2010) A Non Mouse-Adapted Dengue Virus Strain as a New Model of Severe Dengue Infection in AG129
Mice. PLoS Negl Trop Dis 4(4): e672. doi:10.1371/journal.pntd.0000672
Editor: Eva Harris, University of California, Berkeley, United States of America
Received December 8, 2009; Accepted March 18, 2010; Published April 27, 2010
Copyright:  2010 Tan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the National Medical Research Council (Individual Research Grant # NMRC/1042/2006, and Translational and Clinical
Research Grant ‘‘STOP Dengue’’). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: micas@nus.edu.sg
Introduction
Dengue (DEN) virus belongs to the Flaviviridae family, Flavivirus
genus, and is the causative agent of DEN disease, a mosquito-
borne illness that is endemic in subtropical and tropical countries
[1]. With approximately half of the world’s population residing in
DEN endemic regions [2] and more than 50 million new
infections projected to occur annually [3], DEN certainly poses
as a global economic and health threat.
Infection with one of the four DEN serotypes can be
asymptomatic or trigger a wide spectrum of clinical manifestations,
ranging from mild acute febrile illness to classical dengue fever
(DF), and to severe dengue hemorrhagic fever/dengue shock
syndrome (DHF/DSS), characterized by fever, hemorrhagic
tendency, thrombocytopenia, and capillary leakage according to
the WHO guidelines [4]. Despite the increasing attention and
research efforts devoted to DEN in recent years, the cellular and
molecular mechanisms responsible for DEN pathogenesis remain
largely unknown. Current hypotheses for the development of
severe DEN that involve dysfunction of the host immune system
include enhancing mechanisms induced by sub-neutralizing cross-
reactive antibodies and memory T cells [3,5]. Other non-
enhancing mechanisms implicating the immune system include
auto-immune responses against cross-reactive viral components,
such as DEN non-structural 1 (NS1) protein [6,7]. Platelet lysis,
nitric oxide-mediated apoptosis of endothelial cells and comple-
ment activation have also been proposed to mediate thrombocy-
topenia and vascular leakage [8]. In addition, host genetic
predisposition [9–11] and virus virulence [12,13] were reported
as risk factors for the development of severe DEN.
No effective drugs or vaccines against DEN are currently
available on the market [14]. Undeniably, progress in deciphering
the mechanisms responsible for DEN pathogenesis and in
developing effective prophylactic and/or therapeutic treatments
has been impeded by the lack of suitable animal models [15].
Humans and mosquitoes represent so far the only natural hosts for
DEN virus. Non-human primates have been reported to be
permissive to DEN infection but no apparent clinical symptoms of
the disease were observed [16,17], although a recent study
reported signs of hemorrhage in rhesus macaques intravenously
infected with a high dose of a DEN2 virus strain [18]. In addition,
since the infected animals develop transient viremia and antibody
responses, they have been useful for evaluating the efficacy of
vaccine and antiviral candidates prior to clinical trials in humans
[19,20]. However, for ethical and economical reasons, non-human
primates do not represent a sustainable option for DEN research.
Alternatively, the mouse model has been explored [15]. However,
most of the DEN virus laboratory strains and clinical isolates do
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displayed a higher infectivity but led to irrelevant clinical
manifestations such as paralysis [21,22]. Alternatively, a variety
of mouse genetic backgrounds have been explored that displayed
greater susceptibility to DEN infection [23–30]. Among them,
AG129 mice, deficient in interferon (IFN)- a/b and -c receptors,
were shown to allow effective replication of DEN virus [30–33].
However, great heterogeneity in the susceptibility of these mice to
DEN virus strains, even within the same serotype, was reported
[32] with none or few of DEN disease manifestations [30].
Moreover, administration of high viral doses was necessary to
trigger a virulent phenotype which resulted in the animals’ death
within few days at the peak of viremia [30]. This is in contrast to
humans for whom signs of severe DEN generally occur during or
after defervescence when DEN virus is no longer detectable in the
patient’s blood [3,34,35].
Here we describe a unique non mouse-adapted strain of DEN
virus serotype 2 (D2Y98P) which is highly infectious in AG129
mice upon intraperitoneal administration. Infection with a high
viral dose of D2Y98P resulted in an acute model of infection with
mice dying at the peak of viremia, whereas infection with a low
viral dose led to asymptomatic dissemination and replication of the
virus followed by death of the animals after the virus has been
cleared from its host.
Materials and Methods
Ethics statement
All the animal experiments were carried out under the
guidelines of the National University of Singapore animal study
board.
Virus strain and growth conditions
The virus strain used in this study (D2Y98P) derives from a
1998 DEN2 Singapore human isolate that has been exclusively
passaged for about 20 rounds in Aedes albopictus C6/36 cells. C6/36
cells (ATCC# CRL-1660) were maintained in Leibovitz’s L-15
medium (GIBCO) supplemented with 5% fetal calf serum (FCS),
and virus propagation was carried out as described previously
[32]. Virus stocks were stored 280uC. When necessary, heat-
inactivation of the virus was performed at 55uC for 15 min.
Virus quantitation
Plaque assay was carried out to quantify the number of
infectious viral particles using BHK-21 (Baby Hamster Kidney,
ATCC# CCL-10) cells as described previously [36] with slight
modifications. Briefly, BHK cells were cultured to approx. 80%
confluency in 24-well plates (NUNC, NY, USA). The virus stock
was 10-fold serially diluted from 10
21 to 10
28 in RPMI 1640
(GIBCO). BHK-21 monolayers were infected with 100 ul of each
virus dilution. After incubation at 37uC and 5% C02 atmosphere
for 1 hr with rocking at 15 min intervals, the medium was
decanted and 1 ml of 1% (w/v) carboxymethyl cellulose in RPMI
supplemented with 2% FCS was added to each well. After 4 days
incubation at 37uCi n5 %C O 2, the cells were fixed with 4%
paraformaldehyde and stained for 30 min with 200 mlo f1 %
crystal violet dissolved in 37% formaldehyde. After thorough
rinsing with water, the plates were dried and the plaques were
scored visually.
Mice infection
AG129 [129/Sv mice deficient in both alpha/beta (IFN-a/b)
and gamma (IFN-c) interferon receptors] were obtained from
B&K Universal (UK). They were housed under specific pathogen-
free conditions in individual ventilated cages. Eight to 9 week-old
mice were administered with 10
7 to 10
2 plaque forming units
(PFU) of D2Y98P via the intraperitoneal (ip.) route (0.4 ml in
sterile PBS). Where indicated, mice were inoculated with the same
dose and volume of heat-inactivated D2Y98P.
Antibody titres
Systemic antibody titres against D2Y98P were determined by
enzyme-linked immunoadsorbent assay (ELISA) as described
previously [32]. Briefly, 96-well plates (Corning costar, NY,
USA) were coated overnight at 4uC with 10
5 PFU of heat-
inactivated D2Y98P virus in 0.1M NaHCO3 buffer at pH 9.6.
Two-fold serially diluted serum samples (1:25 to 1:25,600) were
added to the wells and incubated for 1 hr at 37uC. HRP-
conjugated anti-mouse IgM (Chemicon) or IgG (H+L) (Bio-rad)
secondary antibody were used at a 1:3,000 dilution. Detection was
performed using SigmaFast
TM O-phenylenediamine dihydrochlo-
ride substrate (Sigma Aldrich) according to the manufacturer’s
instructions. The reaction was stopped with 75 mlo f1 MH 2SO4
and absorbance was read at 490 nm using an ELISA plate reader
(Bio-rad model 680). ELISA titres were defined as the reciprocal of
the highest serum dilution that equals to 3 times the absorbance
reading from uninfected mouse serum sample.
Plaque reduction neutralization test (PRNT)
PRNT was carried out as described previously [36] with
modifications. Briefly, mouse serum samples were heated at 56uC
for 30 min to inactivate complement. Two-fold serial dilutions of
the sera (1:10 to 1:10,240 in RPMI 1640) were mixed in 96-well
plates with an equal volume containing 30 PFU of D2Y98P, and
incubated at 37uC for 1 hr with rocking every 15 min. Each mix
(100 ml) was transferred onto BHK monolayers grown in 24-well
plates, and incubated at 37uC for 1 hr. The mix was decanted, and
plaque assay was carried out as described above. The percentage
of plaque reduction was derived relative to the control consisting of
virus mixed with uninfected serum: [1- (number of plaques in test
wells/number of plaques in control wells) *100]. Fifty percent
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fitting a variable sigmoidal curve in GraphPad Prism 5.00
(GraphPad Software). Data are expressed as the reciprocal of
the highest serum dilution for which PRNT50 is obtained.
Determination of virus titres in infected mice
Blood samples were collected in 0.4% sodium citrate and
centrifuged for 5 min at 6,000 g to obtain plasma. The presence of
infectious viral particles was determined by plaque assay as
described above.
To assess the levels of infectious virus in the tissues from infected
mice, the animals were euthanized and perfused systemically with
50 ml sterile PBS. Whole tissue from the brain, intestines, liver and
spleen were harvested from individual mice, kept on ice and their
wet weights were recorded prior to any further processing.
Samples were then trimmed and homogenized using a mechanical
homogenizer (Omni) for 5 minutes in 1 ml RPMI 1640 at medium
speed on ice. Thoroughly homogenized tissues were clarified by
centrifugation at 14,000 rpm for 10 min at 4uC to pellet debris.
The supernatant was filter-sterilized using a 0.22 mm diameter
pore size filter and the volume was recorded. The level of
infectious virus within the filtrate is thus considered representative
of the total level of infectious virus present in the harvested organ.
Ten-fold serial dilutions of each filtrate (from neat to 1:10
5) were
assayed in a standard virus plaque assay on BHK-21 cells as
described above. Triplicate wells were run for each dilution of
each sample. Data are finally expressed as log10 [mean 6 SD] in
PFU per gram of wet tissue with a limit of sensitivity set at 1.0 log10
PFU/g of tissue. Five mice per time point per group were assessed.
Results are representative of two experiments.
Histology
Mice were euthanized, and tissues were harvested and
immediately fixed in 10% formalin in PBS. Fixed tissues were
paraffin embedded, sectioned and stained with Hematoxylin and
Eosin (H&E).
Vascular leakage assessment
Vascular leakage was assessed using Evans Blue dye as a marker
for albumin extravasation as described previously [30,37] with
modifications. Briefly, 0.2 ml of Evans blue dye (0.5% w/v in PBS)
(Sigma Aldrich) were injected intravenously into the mice. After
2 hrs, the animals were euthanized and extensively perfused with
sterile PBS. Vascular permeability in the tissues was determined
visually and quantitatively; the tissues were harvested and weighed
prior to dye extraction using N,N-dimethylformamide (Sigma;
4 ml/g of tissue wet weight) at 37uC for 24 hrs after which
absorbance was read at 620 nm. Data are expressed as fold
increase in OD620nm per g of tissue wet weight compared to the
uninfected control.
Cytokine detection
Cytokine (IFN-c, TNF-a and IL-6) expression levels were
measured in individual serum samples using individual detection
kits (R&D), according to the manufacturer’ instructions. After
incubation with detection antibodies and streptavidin-PE com-
plexes, absorbance was read at 450 nm. Five mice per group and
per time point were used.
Hematology
Mouse blood samples were collected in K2EDTA and serum
tubes (Biomed Diagnostics). Whole blood was immediately
analysed for cell counts using automated hematology analyzer
Cell Dyn – 3700 (Abbott). Serum alanine (ALT) and aspartate
(AST) aminotransferases, and albumin levels were quantified using
chemistry analyzer COBAS C111 (ROCHE).
Statistical analysis
The results were analyzed using the unpaired Student t test.
Differences were considered significant (*) at p value ,0.05.
Results
Survival rate of D2Y98P-infected AG129 mice
To test the infectious potential of the D2Y98P strain, AG129
mice were intraperitoneally (ip.) infected with 10-fold serially
diluted viral doses ranging from 10
7 to 10
2 PFU. Survival rates
indicated that infection with 10
4 PFU and above induced 100%
mortality whereas 20% and 90% survival rates were observed in
animals infected with 10
3 and 10
2 PFU, respectively (Fig. 1).
Figure 1. Survival rates in AG129 mice infected with a dose range of D2Y98P virus. AG129 mice were infected intraperitoneally (ip.) with
10-fold serially diluted viral doses of D2Y98P ranging from 10
7 to 10
2 PFU. Ten mice per group were used. Data are representative of at least 3
independent experiments.
doi:10.1371/journal.pntd.0000672.g001
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between viral dose and time-of-death was observed, with increased
heterogeneity as the infectious dose is lower.
Upon infection with 10
7 and 10
6 PFU, initial clinical signs
included ruffled fur and hunched posture, which further
progressed to bloatedness, lethargy, diarrhoea-like symptoms,
moribund state and finally death of the animals. None of the mice
exhibited paralysis or significant body weight loss during the
course of infection (Fig. 2A). In contrast, upon infection with 10
5
PFU and below, no signs of diarrhoea were observed and near
moribund state, rapid body weight loss was measured (Fig. 2B).
Mice ip. inoculated with heat-inactivated D2Y98P (10
7 PFU
equivalent) displayed none of the disease manifestations or death.
In addition, neither disease manifestation nor transient viremia
was observed in immunocompetent Balb/c and C57Bl/6 mice ip.
infected with 10
7 PFU of D2Y98P (data not shown).
Viremia and antibody titres
Although both viral doses eventually induced 100% mortality in
AG129 mice, ip. infection with 10
7 and 10
4 PFU of D2Y98P gave
very different disease kinetics, suggesting that different mecha-
nisms and players are involved in the disease progression. We thus
decided to further characterize both the ‘‘acute’’ and ‘‘delayed’’
models of DEN infection.
Systemic virus titres were monitored over the course of infection
for both viral doses. In mice infected with 10
7 PFU, the peak of
viremia (10
5 PFU/ml) coincided with the animals’ death at 5 days
p.i. (Fig. 3A). In contrast, in mice infected with 10
4 PFU, viremia
peaked at around 10
4 PFU/ml at 6 days p.i., followed by viral
clearance from the blood circulation prior to animal death
(Fig. 3B), similar to the disease kinetic described in severe DEN
patients [3,34,35,38].
Furthermore, specific IgM and IgG antibody titres were
monitored over the course of infection. Significant IgM but
weak IgG responses were measured in mice infected with 10
7
PFU which both peaked at the time of death, 5 days p.i.
( F i g .3 C ) .I n s t e a d ,i nm i c ei n f e c t e dw i t h1 0
4 PFU, significant
IgG antibody titers were detected which progressively
increased over time, while the IgM antibody response peaked
a td a y1 0p . i .a n dw a n e db yd a y1 8p . i .( F i g .3 D ) .N e u t r a l i z i n g
antibody titres correlated with the IgG antibody responses
(Fig. 3E&F).
Tissue tropism and kinetic of virus replication in D2Y98P-
infected mice
Gross pathological examination of the organs within the
intraperitoneal cavity from moribund animals infected with 10
7
PFU of D2Y98P revealed overt abnormalities that included a
severely distended stomach, a significantly enlarged spleen and
focal areas of haemorrhage in the liver, observable after systemic
perfusion of the mice with saline (Fig. 4A). These features were not
observed in moribund animals infected with 10
4 PFU (data not
shown).
Tissue tropism and kinetic of viral replication were deter-
mined in the intestines, liver, spleen, and brain from animals
infected with either 10
7 or 10
4 PFU of D2Y98P. No infectious
viral particles were detected in the intestines. In the spleen, liver
and brain, the kinetic of the virus titers corresponded to the
viremia profile; in animals infected with 10
7 PFU, virus titres in
the infected organs increased logarithmically in conjunction
with disease advancement, reachi n gt h e i rh i g h e s ta tt h et i m eo f
death (Fig. 4B-D). Instead, in animals infected with 10
4 PFU,
the virus titres peaked at 5 or 6 days p.i. in the liver, spleen and
brain, and progressively dropped until complete clearance by
day 8 p.i. (Fig. 4B-D). Interestingly, the peak of virus titres
achieved in the liver and spleen was comparable in both animal
groups whereas peak titres in the brain (Fig. 4D) and plasma
(Fig. 3A&B) were about 1 log higher in mice infected with 10
7
PFU.
Histological examination of organs from D2Y98P-
infected mice
Brain, spleen, liver and intestines were harvested from mice
infected with 10
7 or 10
4 PFU of D2Y98P over the course of
infection. Histological examination of H&E stained-sections from
animals infected with 10
7 PFU revealed progressive damage at
both tissue and cellular levels which culminated at the time of
death (Fig. 5A). The well defined limits of the splenic red and
white pulp began to blur by day 3 p.i. (data not shown) and the
spleen architecture was completely lost by day 5 p.i. (Fig. 5A). A
larger magnification revealed the presence of apoptotic debris.
The liver displayed focal areas of haemorrhage and edema of cell
masses. Lymphoid aggregates and inflammatory infiltrates were
also detected at the portal tract and within the sinusoidal spaces of
the liver (data not shown). At the cellular level, extensive
Figure 2. Body weight changes in D2Y98P-infected mice. Mice were ip. infected with 10
7 or 10
6 (A), or with 10
5 to 10
2 (B) PFU of D2Y98P. Body
weight changes were monitored daily (A) or every other day (B) post-infection (p.i.). Results are expressed as the [mean 6 SD] of body weight loss in
percentage compared to initial body weight. Ten mice per group were monitored. Results are representative of 2 independent experiments.
doi:10.1371/journal.pntd.0000672.g002
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vacuolation and degeneration were observed. Liver damage was
reflected by the significantly increased levels of aspartate (ALT)
and alanine (AST) transaminases measured in the serum of the
infected animals (Fig. 5B). Interestingly, despite the absence of
detectable virus particles in the intestines, these tissues displayed
marked infiltration of inflammatory cells and extensive architec-
tural distortion at moribund state (Fig. 5A). Severe detachment
and disintegration of the intestinal villi resulting in a debris-filled
intestinal lumen was noted.
In animals infected with 10
4 PFU of D2Y98P, no visible organ
damage was noticeable at the peak of viremia, 6 days p.i. (Fig. 5A).
However, at moribund state, the splenic architecture was severely
impaired to an extent comparable to that observed in animals
infected with 10
7 PFU. In contrast, the liver and intestines were
moderately affected with only localized areas of visible damage.
Moderate but significant increase in the systemic levels of ALT
and AST was measured at moribund state (Fig. 5B), indicative of
some liver dysfunction. Apart from slight vascular congestion,
brain sections from both animal groups did not display any
significant pathological changes at any time post-infection
(Fig. 5A).
Vascular leakage in D2Y98P-infected mice
Vascular leakage, a hallmark of severe DEN infection in
humans, was investigated in D2Y98P-infected AG129 mice using
Evans blue dye extrusion assay [30,37]. At moribund state, severe
vascular leakage was observed (Fig. 6A) and measured (Fig. 6B) in
the spleen, liver and intestines from animals infected with 10
7 PFU
compared to uninfected controls. Consistently, significant de-
Figure 3. Viremia and antibody titres in D2Y98P-infected mice. Mice were ip. infected with 10
7 (A, C, E) or 10
4 (B, D, F) PFU of D2Y98P. At the
indicated time points, five infected animals were bled and euthanized immediately. Viremia titres (A, B), specific anti-IgM (black circle) and IgG (open
circle) titers (C, D), and PRNT50 (E, F) were determined for each individual serum. Results are representative of 2 independent experiments.
doi:10.1371/journal.pntd.0000672.g003
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animals, indicative of plasmatic proteins leakage (Fig. 6C).
In animals infected with 10
4 PFU, marginal dye extrusion was
observed in the liver, intestines and spleen at the peak of viremia (6
days p.i.) whereas at moribund state, dye extrusion was markedly
increased in all the organs examined (Fig. 6A&B). The extent of
leakage in the liver and intestines was lesser than that observed in
mice infected with 10
7 PFU, whereas dye extrusion in the spleen
was as high as in the animals infected with 10
7 PFU (Fig. 6B).
Interestingly, and in contrast to animals infected with 10
7 PFU,
serum albumin concentration measured in animals infected with
10
4 PFU was significantly higher than that measured in uninfected
control animals (Fig. 6C), suggestive of hemoconcentration.
Cytokine expression levels in D2Y98P-infected mice
Enhanced cytokine production may lead to increased vascular
permeability and has been proposed to contribute to DHF/DSS
pathogenesis [39,40]. The expression profile of three key pro-
inflammatory cytokines, namely IFN-c, IL-6 and TNF-a, was
monitored over the course of infection in the serum of animals
infected with 10
7 or 10
4 PFU of D2Y98P. In animals infected with
10
7 PFU, the cytokine expression levels increased consistently over
time and peaked at the time of death of the animals (Fig. 7). In
contrast, in animals infected with 10
4 PFU, the production of these
pro-inflammatory cytokines corresponded to the viremia profile,
peaking at day 6 p.i., followed by a progressive decline to reach
basal production levels at moribund stage (Fig. 7). Of note, peak
values of the systemic levels of these three cytokines were
significantly higher in animals infected with 10
7 PFU compared
to animals infected with 10
4 PFU.
Hematology in D2Y98P-infected mice
Hematological disorders have been associated with DEN
disease and tentatively used as diagnostic and prognostic markers
[41,42]. Total counts of red blood cells (RBC), white blood cells
(WBC), lymphocytes, platelets and neutrophils were monitored in
D2Y98P-infected mice over the course of infection (Table 1).
In animals infected with 10
7 PFU, significant increase in RBC
concentration and hematocrit was measured at day 3 p.i.
compared to uninfected controls, indicative of hemoconcentration.
At moribund state however (day 5 p.i.), the levels of RBC and
hematocrit dropped, suggestive of hemorrhage. However, the
levels of WBC, neutrophils and platelets increased substantially
over time. Transient depletion in lymphocyte counts was observed
at day 3 p.i. followed by significant increase at day 5 p.i.
In animals infected with 10
4 PFU, progressive increase in RBC
counts and hematocrit was observed over the course of infection,
indicative of hemoconcentration. WBC, neutrophils, and platelets
levels similarly increased progressively and reached peak values at
10 days p.i. At moribund state however, the levels measured were
Figure 4. Pathology and virus titres in the liver, spleen and brain of D2Y98P-infected mice. (A) Mice were ip. infected with 10
7 PFU of
D2Y98P, and were sacrificed at moribund state and perfused extensively with PBS. Representative gross appearance of organs in the intraperitoneal
cavity of uninfected (left panel) and ip. infected (right panel) mice. Insets highlight the difference in the spleen size between both animal groups.
Virus titres were determined in the liver (B), spleen (C) and brain (D) from AG129 mice ip. infected with 10
7 (black circle) or 10
4 (open circle) PFU of
D2Y98P virus. Results are expressed as log10 [mean 6 SD] in PFU per gram of tissue. Five mice per time point per group were assessed. Results are
representative of 2 independent experiments.
doi:10.1371/journal.pntd.0000672.g004
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lymphopenia was observed at the peak of viremia (day 6 p.i.)
followed by a very significant increase at day 10 p.i. Basal
lymphocytes level was measured at moribund state.
Altogether, the hematological parameters indicate that infection
with 10
7 PFU of D2Y98P led to haemorrhage tendency, whereas
infection with 10
4 PFU resulted in hemoconcentration. Remark-
ably, no evidence of thrombocytopenia was observed in the
infected animals as reflected by the platelets counts which were not
found statistically different from the uninfected controls.
Discussion
A growing number of immunocompetent, immunosuppressed
and humanized mouse models of DEN infection have been
explored, using an increasing number of mouse-adapted or cell-
Figure 5. Histopathology of D2Y98P-infected mice. (A) Representative H&E-stained tissue sections from the spleen, liver, intestines and brain
of AG129 mice ip. infected with 10
7 or 10
4 PFU of D2Y98P virus. Animals were euthanized at day 6 p.i. (10
4 PFU dose) or at moribund state (10
4 and
10
7 PFU doses). Sections were viewed under a light microscope at 50x (spleen) or 100x (liver, intestines, brain) magnifications. Insets at the right
bottom corners are observations made at 400x magnification. Representative sections from uninfected animals are shown in the left panels. Arrows
indicate apoptotic debris (inset spleen), hemorrhage and edema (liver) or vacuolation of hepatocytes (inset liver), and inflammatory cells (inset
intestines). Legend: RP, red pulp; WP, white pulp. (B) Serum levels of aspartate (AST) and alanine (ALT) transaminases. Mice were ip. infected with 10
7
or 10
4 PFU of D2Y98P. The animals were bled and euthanized at day 6 p.i. (10
4 PFU) or at moribund state (10
4 and 10
7 PFU). Five mice per group and
per time point were used. Results are expressed in U/L as the [mean 6 SD] and are representative of 2 independent experiments.
doi:10.1371/journal.pntd.0000672.g005
Figure 6. Vascular leakage in D2Y98P-infected mice. AG129 mice were inoculated ip. with 10
7 or 10
4 PFU of D2Y98P. At day 6 p.i. (10
4 PFU
dose) or at moribund state (both doses), mice were intravenously administered with Evans blue. After 2 hours, they were perfused extensively with
PBS and assessed for Evans Blue extravasation in tissues. (A) Evan’s blue extravasation in the peritoneal cavity (top panel) and intestines (bottom
panel) of uninfected or D2Y98P-infected mouse at moribund state. (B) Quantification of Evans blue dye in the intestine, liver and spleen from mice.
Five animals per group per time point were individually processed. Data are expressed as the [mean 6 SD] of fold increases in OD620nm per gram of
wet tissue compared to uninfected controls. (C) Serum albumin concentration. Results are expressed as the [mean 6 SD] of 5 animals per time point
per group. *p,0.05. Results are representative of 2 independent experiments.
doi:10.1371/journal.pntd.0000672.g006
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so far managed to recapitulate all the clinical symptoms and
manifestations of DEN disease as observed in humans. As humans
and mosquitoes represent the only two natural hosts for DEN
virus, it is unrealistic to hope address all the features of DEN
pathogenesis in a single mouse model. However, previous studies
have shown that it is possible to reproduce, and thus study, one or
few aspects of DEN pathogenesis in a specific mouse model of
DEN infection defined by a particular mouse background infected
with a specific DEN virus strain through a particular route of
administration and at a particular infectious dose. For example, a
mouse model of DEN hemorrhage has recently been reported
through intradermal infection of immunocompetent mice with a
high dose of the non-mouse adapted DEN2 virus strain 16681
originally isolated from a DHF patient [43,44]. Likewise, a
humanized mouse strain infected subcutaneously with various
DEN virus strains reportedly displayed clinical signs of DEN fever,
including fever, viremia, erythema, and thrombocytopenia [45].
Similarly, the AG129 mouse model has allowed the investigation
of some aspects of DEN pathogenesis including virus tropism,
vascular leakage, and pathogenesis in context of a functional
adaptive immune system [33]. Furthermore, the AG129 mouse
background has proven useful for vaccine and drug testing
[31,32]. However, the lack of IFN a/b2 and c2signalling draws
some limitations and calls for cautious interpretation of the
findings and observations made in this mouse model. Further-
more, the susceptibility of AG129 mice to DEN infection appears
to greatly depend on the DEN virus strain [32] and a limited
number only have so far been reported to result in a productive
infection with no, few or irrelevant clinical manifestations [30,32].
Moreover, administration of high viral doses was necessary to
trigger a virulent phenotype which resulted in animal death within
few days at the peak of viremia [30].
Here we describe a non mouse-adapted DEN virus strain,
D2Y98P, which is highly infectious in AG129 mice. D2Y98P is a
serotype 2 DEN virus strain originally isolated in 1998 from a
Singapore DEN-infected patient whose disease status at the time of
sample collection, and disease outcome are unfortunately not
known. The virus has been exclusively amplified in mosquito cells
for less than 20 rounds. Interestingly, an earlier passage (P13)
displayed a more attenuated virulent phenotype upon infection of
AG129 mice (G. Tan, personal communication). This observation
therefore suggests that mutation(s) have occurred in the viral
genome upon amplification in mosquito cells that rendered the
virus more virulent. Identification of the nucleotide changes
between the two virus passages is currently in progress in our
laboratory.
Infection of AG129 mice with a high dose (10
7 PFU) of
D2Y98P induced an acute lethal DEN infection where the peak
of viremia and virus titres in the infected organs coincided with
death of the animals, accompanied by cytokine storm, massive
organ damage, and severe vascular damage leading to haemor-
rhage. It is thus likely that in this acute model of DEN infection,
the pathological events are a consequence of both virus-induced
Figure 7. Pro-inflammatory cytokine expression in D2Y98P-infected mice. AG129 mice were ip. infected with 10
7 or 10
4 PFU of D2Y98P,
bled at the indicated time points and immediately euthanized. Serum levels of IFN-c (A), IL-6 (B) and TNF-a (C) were quantified. Results are expressed
in pg/ml as the [mean 6 SD] of 5 mice per time point and per group.
doi:10.1371/journal.pntd.0000672.g007
Table 1. Hematology in D2Y98P-infected mice.
Cell types Uninfected 10
7 PFU 10
4 PFU
Day 3 p.i. Moribund Day 6 p.i. Day 10 p.i. Moribund
WBC 4.85 (0.54) 5.68 (0.68) 24.32* (1.61) 9.49* (1.23) 20.76* (4.75) 4.33 (0.73)
NEU 0.54 (0.09) 3.49* (0.21) 8.17* (1.14) 6.35* (1.19) 8.03* (2.67) 1.07* (0.09)
LYM 3.86 (0.36) 1.25* (0.11) 8.2* (2.07) 2.23* (0.31) 10.88* (2.34) 2.99 (1.00)
RBC 7.56 (0.31) 9.58* (0.27) 7.31 (0.53) 9.48* (0.54) 9.95* (0.21) 10.87* (0.43)
HCT 41.10 (1.2) 47.22* (1.14) 38.22 (2.6) 45.34* (2.36) 47.78* (0.92) 53.88* (1.11)
PLT 464.6 (65.4) 427.2 (26.1) 552.8 (43.3) 476.2 (23.33) 706.2* (40.85) 499.8 (42.87)
AG129 mice were ip. infected with 10
7 or 10
4 PFU of D2Y98P. At the indicated time points, 5 mice per group per time point were bled and euthanized. Blood samples
were processed to determine white blood cells (WBC), neutrophils (NEU), lymphocytes (LYM), red blood cells (RBC), hematocrit (HCT), and platelets (PLT) counts. A
group of uninfected mice was included as control. WBC, NEU, LYM and PLT counts are given in K/uL (10
3 cells/ul), RBC count in M/uL (10
6 cells/ul), and HCT in
percentage (%). Data are expressed as the [mean 6 SD] of individual measurements and are representative of 2 independent experiments. * p,0.05 compared to
uninfected controls.
doi:10.1371/journal.pntd.0000672.t001
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virulent phenotype is similar to that described previously by
Shresta and colleagues using the D2S10 DEN virus strain [30]. In
contrast, infection of AG129 mice with a lower dose (10
4 PFU) of
D2Y98P led to a transient asymptomatic systemic viral infection
followed by death of the animals few days after viral clearance,
similar to the disease kinetic described in humans [3,38]. A strong
neutralizing IgG antibody response was measured in the infected
animals and is likely to be involved in the viral clearance.
Although increased vascular permeability (as indicated by
increased serum albumin concentration and Evan’s blue dye
extrusion) was observed in the moribund animals, the actual
cause of the animals’ death remains elusive. Apparent destruction
of the splenic architecture and liver dysfunction at moribund
stage are likely to contribute to the sickness. Furthermore, as the
disease progressed, infected animals appeared lethargic and
displayed reduced motility. This may result in reduced water
intake and dehydration of the animal, hence contributing to the
sharp body weight loss observed towards moribund stage and
consequently leading to animal death.
Widespread immune activation in response to acute DEN
infection has been well documented in DEN patients, and
circulating levels of various pro-inflammatory cytokines were
found to be elevated in patients with severe DEN [40]. Likewise,
the levels of three key pro-inflammatory cytokines implicated in
DF/DHF, namely IL-6, TNF-a and IFN-c, were significantly
elevated in the D2Y98P-infected AG129 mice and were directly
dependent on the initial infectious dose. Consistently, extensive
damage of various organs including the spleen, liver and
intestines was observed in animals infected with a high viral
dose (10
7 PFU). In contrast, lower levels of cytokine production in
animals infected with a low viral dose (10
4 PFU) correlated with
milder organ damage except for the spleen that appeared at
moribund stage, to be as extensively damaged as in animals
infected with a high viral dose; the absence of infectious viral
particles in the moribund animals excludes a direct virus
cytopathic effect but rather suggests some immunological
disorder that may arise from the overstimulation of immune
cells possibly by persistent viral antigens.
In contrast to the liver and spleen, no histological damage or
abnormalities were detected in the brain of animals infected with
10
7 PFU or 10
4 PFU, although infectious viral particles were
readily detected in this tissue after systemic perfusion. This
observation suggests that the virus is capable of extravasating from
the systemic circulation and cross the blood-brain barrier but may
not effectively replicate in the brain. Therefore, in this mouse
model, and as reported in dengue patients [46,47], meningitis
and/or encephalitis may not contribute significantly to disease
severity.
The action of a variety of cytokines, chemokines, and other
soluble mediators on endothelial cells has been proposed to affect
vascular permeability during DEN infection [39]. Vascular
leakage is a hallmark of DHF/DSS leading to hemoconcentration
and hemorrhagic manifestations [41,48], as observed in mice
infected with 10
7 PFU of D2Y98P for whom focal areas of
haemorrhage were observed in the liver, and low hematocrit and
serum albumin levels were measured. In this animal group, high
levels of pro-inflammatory cytokines are likely responsible for the
observed severe vascular leakage, particularly in the intestines
where no infectious viral particles were detected.
However, in mice infected with 10
4 PFU, neither significant
vascular leakage nor hemorrhage was detected at the peak of
viremia despite elevated levels of IFN-c,I L - 6a n dT N F - a.
Instead, increased vascular permeability was clearly observed at
moribund stage where the production of these three cytokines has
returned to basal level. This observation suggests that other pro-
inflammatory cytokines may be involved in the increased vascular
permeability observed in this low viral dose infection model.
Indeed, in addition to IFN-c, IL-6 and TNF-a, a number of
cytokines, chemokines and other soluble mediators have been
demonstrated or proposed to play a role in vascular leakage in
DEN disease [39]. Alternatively or additionally, other mediators
previously proposed to increase vascular permeability such as
immune complexes [49], nitrite oxide production [39], or cross-
reactive anti-NS1 antibodies [6,7], may be at play. Furthermore,
hemoconcentration and increased serum albumin level suggests
that fluid only but not proteins or cells, leaks from the blood
vessels. Increased vascular permeability without morphological
damage of the capillary endothelium is believed to be the cardinal
feature of DSS [39,49] and thus appears to be reproduced in this
mouse model of DEN infection. Further investigation is however
needed to decipher the actual mechanisms underlying this
phenomenon.
Remarkably, thrombocytopenia, a hallmark of severe disease in
DEN patients, was not detected in the animals infected with
D2Y98P virus, regardless of the initial infectious dose. Transient
drop in platelet counts has been previously observed in a number
of mouse models of DEN infection [15] including AG129 [33],
ruling out the possibility that the lack of IFNc signalling in these
mice would impair the mechanism(s) involved in thrombocytope-
nia. The absence of thrombocytopenia in our model may thus be
inherent to the D2Y98P virus strain. A number of immunological
mechanisms and effectors have been proposed to play a role in
thrombocytopenia during DEN infection [50–53], but the
differential ability of DEN virus strains to induce thrombocytope-
nia in a single model of DEN infection has never been
investigated.
In conclusion, the attractiveness of the D2Y98P strain lies in its
ability to induce, without the need for mouse-adaptation and upon
peripheral administration of a low viral dose, a virulent phenotype
in AG129 mice with a productive viral replication and
dissemination accompanied by some relevant clinical manifesta-
tions, including disease kinetic, organ damage/dysfunction and
increased vascular permeability. This model thus offers the
opportunity to further dissect some of the mechanisms involved
in DEN pathogenesis with the caveat that AG129 mice are
defective in IFN signalling. Furthermore, the induction of a disease
kinetic where the time-of-death window is distinct from the
viremic phase makes this low viral dose model unique and an
attractive platform for assessing the efficacy of DEN vaccine and
drug candidates.
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